EX-10.8 14 g06286exv10w8.htm EX-10.8 STRATEGIC ALLIANCE AGREEMENTStrategic Alliance Agreement • May 5th, 2020 • Tennessee
Contract Type FiledMay 5th, 2020 JurisdictionEXHIBIT 10.8 *Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. STRATEGIC ALLIANCE AGREEMENT THIS AGREEMENT is made and entered into as of the 21st day of July, 2000. BY AND BETWEEN: CUMBERLAND PHARMACEUTICALS INC., a corporation organized and existing under the laws of Tennessee, with its principal offices located at 209 Tenth Avenue South, Suite 332, Nashville, Tennessee, 37203 (hereinafter referred to as “CUMBERLAND”) AND: F.H. FAULDING & CO. LIMITED (ABN 88 007 870 984), a corporation organized under the laws of South Australia, with its principal place of business located at 115 Sheriff Street, Underdale, South Australia 5032 (hereinafter referred to as “FAULDING”); WHEREAS, CUMBERLAND is the owner of intellectual property rights, formulations and know- how related to intravenous formulations of a certain pharmaceutical product set forth in Schedule I; WHEREAS, FAULDING has the expertis
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. STRATEGIC ALLIANCE AGREEMENTStrategic Alliance Agreement • July 23rd, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Contract Type FiledJuly 23rd, 2007 Company Industry JurisdictionCUMBERLAND PHARMACEUTICALS INC., a corporation organized and existing under the laws of Tennessee, with its principal offices located at 209 Tenth Avenue South, Suite 332, Nashville, Tennessee, 37203 (hereinafter referred to as “CUMBERLAND”)
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. STRATEGIC ALLIANCE AGREEMENTStrategic Alliance Agreement • July 11th, 2007 • Cumberland Pharmaceuticals Inc • Pharmaceutical preparations • Tennessee
Contract Type FiledJuly 11th, 2007 Company Industry JurisdictionCUMBERLAND PHARMACEUTICALS INC., a corporation organized and existing under the laws of Tennessee, with its principal offices located at 209 Tenth Avenue South, Suite 332, Nashville, Tennessee, 37203 (hereinafter referred to as “CUMBERLAND”)
Certain portions of this exhibit have been omitted pursuant to a request for confidential treatment which has been filed separately with the SEC. STRATEGIC ALLIANCE AGREEMENTStrategic Alliance Agreement • May 1st, 2007 • Cumberland Pharmaceuticals Inc • Tennessee
Contract Type FiledMay 1st, 2007 Company JurisdictionCUMBERLAND PHARMACEUTICALS INC., a corporation organized and existing under the laws of Tennessee, with its principal offices located at 209 Tenth Avenue South, Suite 332, Nashville, Tennessee, 37203 (hereinafter referred to as “CUMBERLAND”)